
Genetic analysis finds 125 loci shared by insomnia and CRP, with Mendelian randomization favoring an effect from insomnia liability to inflammation.
Supplements and Featured Publications
This clinical brief was sponsored by Dexcom, Inc.
The objective of this clinical brief is to help managed care decision makers evaluate whether coverage policies for continuous glucose monitoring (CGM) should evolve for adults with type 2 diabetes (T2D) who are not treated with insulin. The brief focuses on the evidence most relevant to payers, pharmacy benefit managers, policy makers, and health system leaders: updated clinical guidance, randomized and real-world outcomes, health care resource utilization (HCRU), quality measurement, and remaining access gaps.





